Cargando…
A qualitative examination of the current management of opioid use disorder and barriers to prescribing buprenorphine in a Canadian emergency department
BACKGROUND: Emergency departments (EDs) across Canada are increasingly prescribing buprenorphine for opioid use disorder (OUD). The objective of this study was to identify the current knowledge, attitudes, and behaviours of ED physicians on the management of OUD in the ED, including barriers and fac...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8051038/ https://www.ncbi.nlm.nih.gov/pubmed/33858328 http://dx.doi.org/10.1186/s12873-021-00443-1 |
_version_ | 1783679685221154816 |
---|---|
author | Wiercigroch, David Hoyeck, Patricia Sheikh, Hasan Hulme, Jennifer |
author_facet | Wiercigroch, David Hoyeck, Patricia Sheikh, Hasan Hulme, Jennifer |
author_sort | Wiercigroch, David |
collection | PubMed |
description | BACKGROUND: Emergency departments (EDs) across Canada are increasingly prescribing buprenorphine for opioid use disorder (OUD). The objective of this study was to identify the current knowledge, attitudes, and behaviours of ED physicians on the management of OUD in the ED, including barriers and facilitators to prescribing buprenorphine. METHODS: We purposefully selected emergency physicians from one ED in Toronto which had recently received education on OUD management and had a new addiction medicine follow-up clinic, to participate in semi-structured interviews. We used semi-structured interviews to explore experiences with patients with OUD, conceptions of role of the ED in addressing OUD, and specifically ask about perceptions and experience on using buprenorphine for opioid withdrawal. Our analysis was informed by constructivist grounded theory to help uncover contextualized social processes and focus on what people do and why they do it. Two researchers independently coded transcripts using an iterative constant comparative and interpretative approach. RESULTS: Results fell broadly into facilitators and barriers. Generally, management of OUD in the ED varied significantly. Physician-level facilitators to treating opioid withdrawal with buprenorphine included: knowledge about OUD an7d buprenorphine, positive experiences with substitution therapy in the past, and the presence of physician champions. Systems-level facilitators included timely access to follow-up care and pre-printed order sets. Barriers included provider inexperience, lack of feedback on treatment effectiveness, limited time to counsel patients, and pressure to discharge patients quickly. Additional barriers included concerns about precipitating withdrawal, prescribing a chronic medication in acute care, and patient attitudes. CONCLUSION: This study describes barriers and facilitators to addressing OUD and prescribing buprenorphine in a Canadian ED. These findings suggest a role for additional provider education, involvement of allied health professionals in counseling, and mentorship by physician champions in the department. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12873-021-00443-1. |
format | Online Article Text |
id | pubmed-8051038 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-80510382021-04-19 A qualitative examination of the current management of opioid use disorder and barriers to prescribing buprenorphine in a Canadian emergency department Wiercigroch, David Hoyeck, Patricia Sheikh, Hasan Hulme, Jennifer BMC Emerg Med Research BACKGROUND: Emergency departments (EDs) across Canada are increasingly prescribing buprenorphine for opioid use disorder (OUD). The objective of this study was to identify the current knowledge, attitudes, and behaviours of ED physicians on the management of OUD in the ED, including barriers and facilitators to prescribing buprenorphine. METHODS: We purposefully selected emergency physicians from one ED in Toronto which had recently received education on OUD management and had a new addiction medicine follow-up clinic, to participate in semi-structured interviews. We used semi-structured interviews to explore experiences with patients with OUD, conceptions of role of the ED in addressing OUD, and specifically ask about perceptions and experience on using buprenorphine for opioid withdrawal. Our analysis was informed by constructivist grounded theory to help uncover contextualized social processes and focus on what people do and why they do it. Two researchers independently coded transcripts using an iterative constant comparative and interpretative approach. RESULTS: Results fell broadly into facilitators and barriers. Generally, management of OUD in the ED varied significantly. Physician-level facilitators to treating opioid withdrawal with buprenorphine included: knowledge about OUD an7d buprenorphine, positive experiences with substitution therapy in the past, and the presence of physician champions. Systems-level facilitators included timely access to follow-up care and pre-printed order sets. Barriers included provider inexperience, lack of feedback on treatment effectiveness, limited time to counsel patients, and pressure to discharge patients quickly. Additional barriers included concerns about precipitating withdrawal, prescribing a chronic medication in acute care, and patient attitudes. CONCLUSION: This study describes barriers and facilitators to addressing OUD and prescribing buprenorphine in a Canadian ED. These findings suggest a role for additional provider education, involvement of allied health professionals in counseling, and mentorship by physician champions in the department. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12873-021-00443-1. BioMed Central 2021-04-15 /pmc/articles/PMC8051038/ /pubmed/33858328 http://dx.doi.org/10.1186/s12873-021-00443-1 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Wiercigroch, David Hoyeck, Patricia Sheikh, Hasan Hulme, Jennifer A qualitative examination of the current management of opioid use disorder and barriers to prescribing buprenorphine in a Canadian emergency department |
title | A qualitative examination of the current management of opioid use disorder and barriers to prescribing buprenorphine in a Canadian emergency department |
title_full | A qualitative examination of the current management of opioid use disorder and barriers to prescribing buprenorphine in a Canadian emergency department |
title_fullStr | A qualitative examination of the current management of opioid use disorder and barriers to prescribing buprenorphine in a Canadian emergency department |
title_full_unstemmed | A qualitative examination of the current management of opioid use disorder and barriers to prescribing buprenorphine in a Canadian emergency department |
title_short | A qualitative examination of the current management of opioid use disorder and barriers to prescribing buprenorphine in a Canadian emergency department |
title_sort | qualitative examination of the current management of opioid use disorder and barriers to prescribing buprenorphine in a canadian emergency department |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8051038/ https://www.ncbi.nlm.nih.gov/pubmed/33858328 http://dx.doi.org/10.1186/s12873-021-00443-1 |
work_keys_str_mv | AT wiercigrochdavid aqualitativeexaminationofthecurrentmanagementofopioidusedisorderandbarrierstoprescribingbuprenorphineinacanadianemergencydepartment AT hoyeckpatricia aqualitativeexaminationofthecurrentmanagementofopioidusedisorderandbarrierstoprescribingbuprenorphineinacanadianemergencydepartment AT sheikhhasan aqualitativeexaminationofthecurrentmanagementofopioidusedisorderandbarrierstoprescribingbuprenorphineinacanadianemergencydepartment AT hulmejennifer aqualitativeexaminationofthecurrentmanagementofopioidusedisorderandbarrierstoprescribingbuprenorphineinacanadianemergencydepartment AT wiercigrochdavid qualitativeexaminationofthecurrentmanagementofopioidusedisorderandbarrierstoprescribingbuprenorphineinacanadianemergencydepartment AT hoyeckpatricia qualitativeexaminationofthecurrentmanagementofopioidusedisorderandbarrierstoprescribingbuprenorphineinacanadianemergencydepartment AT sheikhhasan qualitativeexaminationofthecurrentmanagementofopioidusedisorderandbarrierstoprescribingbuprenorphineinacanadianemergencydepartment AT hulmejennifer qualitativeexaminationofthecurrentmanagementofopioidusedisorderandbarrierstoprescribingbuprenorphineinacanadianemergencydepartment |